The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab emtansine (T-DM1) and ribociclib, an oral inhibitor of cyclin dependent kinase 4 and 6 (CDK 4/6), for patients with metastatic HER2-positive breast cancer.
 
Laura Spring
Honoraria - Dava Oncology
Consulting or Advisory Role - Novartis
Research Funding - Tesaro (Inst)
Travel, Accommodations, Expenses - Novartis
 
Shom Goel
Employment - AstraZeneca (I)
Honoraria - Lilly
Consulting or Advisory Role - G1 Therapeutics; Lilly; Novartis
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly; Novartis
 
Sara Sutherland
No Relationships to Disclose
 
Jeffrey G. Supko
No Relationships to Disclose
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; Novartis
Research Funding - Eisai; EMD Serono; Genentech; Novartis; Placon; Takeda
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Genentech/Roche; Hengrui Therapeutics; Immunomedics; Myriad Genetics; PharmaMar; Puma Biotechnology
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); OncoPep (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Erica L. Mayer
Consulting or Advisory Role - Context Therapeutics; Eisai; Lilly; Novartis; Pfizer
Research Funding - Myriad Genetics (Inst); Pfizer (Inst)
 
Beverly Moy
Consulting or Advisory Role - Dark Canyon Labs (I); MOTUS (I); Remedy Partners (I)
Research Funding - Puma Biotechnology (Inst)
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Celldex; Eisai; Genentech; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology; Sanofi; Tesaro
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Merck (Inst); Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics